Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: Quinone oxidoreductase polymorphisms and pancreatic cancer risk

Pancreas

Volumn 40, Issue 1, 2011, Pages 72-78

  Mohelnikova Duchonova, Beatrice ^a,b   Marsakova, Lenka ^a,b   Vrana, David ^a,c   Holcatova, Ivana ^c   Ryska, Miroslav ^b   Smerhovsky, Zdenek ^b   Slamova, Alena ^c   Schejbalova, Miriam ^c   Soucek, Pavel ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

cancer; pancreas; quinone oxidoreductase; superoxide dismutase; susceptibility

Indexed keywords

ALCOHOL; ARGININE; GLYCINE; LEUCINE; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE:QUINONE OXIDOREDUCTASE; OXIDOREDUCTASE; PHENYLALANINE; QUINONE OXIDOREDUCTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; COFFEE; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NQO1 GENE; NQO2 GENE; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; SMOKING; SOD2 GENE; SOD3 GENE; TEA;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; QUINONE REDUCTASES; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 78650951198     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181f74ad7     Document Type: Article

References (37)

1. Cancer Incidence 2007 in the Czech Republic, IHIS CR, NOR CR, Czech Republic, 2010, ISSN 1210 857X.
2. Jamal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71-96.
3. Lo AC, Soliman AS, El-Ghawalby N, et al. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas. 2007;35:120-129.
4. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995;273:1605-1609.
5. Mukesh V. Pancreatic cancer epidemiology. Technol Cancer Res Treat. 2005;4:295-301.
6. Jiao L, Silverman DT, Schairer C, et al. Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2009;169:1043-1051.
7. Rohrmann S, Linseisen J, Vrieling A, et al. Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2009;20:785-794.
8. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol. 2000; 10:349-360.
9. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer. 1996;32A:30-38.
10. Hussain SP, Aguilar F, Amstad P, et al. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene. 1994;9:2277-2281. (Pubitemid 24228678)
11. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
12. Fridovich I. The biology of oxygen radicals. Science. 1978;201: 875-880.
13. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 1996;226:561-565.
14. Wang Li, Miller DP, Sai Y, et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst. 2001;93:1818-1821.
15. Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004;25:973-978. (Pubitemid 38886083)
16. Bergman M, Ahnström M, Palmebäck-Wegman P, et al. Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol. 2005; 131:439-444.
17. Rajaraman P, Hutchinson A, Rothman N, et al. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol. 2008;10:709-715.
18. Woodson K, Tangrea JA, Lehman TA, et al. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control. 2003;14:513-518.
19. Wheatley-Price P, Asomaning K, Reid A, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112: 1037-1042.
20. Wu K, Knox R, Sun XZ, et al. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Arch Biochem Biophys. 1997;347:221-228. (Pubitemid 27492792)
21. Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A. 2001;98:1188-1193.
22. Siegel D, Anwar A, Winski SL, et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol. 2001;59:263-268.
23. Jamieson D, Wilson K, Pridgeon S, et al. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism. Clin Cancer Res. 2007;13: 1584-1590.
24. Lyn-Cook BD, Yan-Sanders Y, Moore S, et al. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: a potential biomarker of early damage in the pancreas. Cell Biol Toxicol. 2006;22:73-80.
25. Mohelnikova-Duchonova B, Vrana D, Holcatova I, et al. CYP2A13, ADH1B and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas. 2010;39:144-148.
26. Khandrika L, Kumar B, Koul S, et al. Oxidative stress in prostate cancer Cancer Lett. 2009;282:125-136.
27. Mena S, Ortega A, Estrela JM. Oxidative stress in environmental-induced carcinogenesis. Mutat Res. 2009;674:36-44.
28. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res. 2005;569: 101-110.
29. Wittel UA, Pandey KK, Andrianifahanana M, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006;101:148-159.
30. Hao J, Li G, Pang B. Evidence for cigarette smoke-induced oxidative stress in the rat pancreas. Inhal Toxicol. 2009;21:1007-1012.
31. Del Guerra S, Lupi R, Marselli L, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes. 2005;54: 727-735.
32. Kang D, Lee KM, Park SK, et al. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev. 2007;16:1581-1586.
33. Vineis P, Veglia F, Garte S, et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol. 2007;18:1230-1242.
34. Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003;26:23-27.
35. Cullen JJ, Hinkhouse MM, Grady M, et al. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 2003;63:5513-5520.
36. Cullen JJ, Weydert C, Hinkhouse MM, et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 2003;63:1297-1303.
37. Bartsch H, Malaveille C, Lowenfels AB, et al. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur J Cancer Prev. 1998;7:215-223.